Rochester, NY 9/1/2009 10:29:09 PM
CAS Medical Systems, Inc. CASM, Down 13.07% on the pre market
CAS Medical Systems, Inc.
CAS Medical Systems, Inc., announced today a new 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the labeling for its FORE-SIGHT(r) Cerebral Oximeter. The new labeling allows FORE-SIGHT to be used on all patients, including those weighing less than 2.5 Kilograms (kg).
http://StockEinstein.com offers free daily stock alerts on companies ready to run. Scroll to BOTTOM of this page for free stock alerts, or visit our site.
Last Trade: 6.39
Day's Range: 6.37 - 6.53
52wk Range: 3.45 - 16.28
Change: Down 0.06 (0.93%)
Volume: 6,898
Avg Vol (3m): 31,244.6
About CAS Medical Systems, Inc.
CAS Medical Systems, Inc. (CASMED) develops manufactures and markets medical devices for non-invasive patient monitoring. The Company’s products include cerebral oximeters and sensors, bedside monitoring products, blood pressure measurement technology, blood pressure cuffs and neonatal supplies. CASMED’s recent addition FORE-SIGHT cerebral oximeter is designed to measure absolute levels of brain oxygenation in critically ill patients, including pediatric and neonatal intensive care patients and adults undergoing cardiac bypass surgery. The Company has several categories of products and services, which include critical care monitoring; bedside monitoring; blood pressure measurement technology, and supplies and service.
About Stock Einstein
StockEinstein uses proprietary technologies coupled with years of experience to uncover stocks we feel have the greatest potential for breakout performance. We utilize not only software, but time tested criteria to uncover these potential winners. When these benchmarks are reached or exceeded, our subscribers are immediately notified.
This service is free and available only to subscribers. Scroll to the bottom of this page to signup for free stock alerts and visit our site.Disclaimer: Full disclaimer at http://StockEinsteain.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinsteain, nor any of its affiliates are registered investment advisors or broker dealers.
